Managing obesity like any other chronic condition - Long-term therapy may reduce comorbidity as well

被引:1
作者
Agrawal, M [1 ]
Worzniak, M [1 ]
Diamond, L [1 ]
机构
[1] Oakwood Hosp, Dearborn, MI USA
关键词
D O I
10.3810/pgm.2000.07.1158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients often seek help from their primary care physician for weight loss, so familiarity with pharmacologic options and their risks is important. Anorexiants have been available for decades and are relatively safe. Orlistat and sibutramine are two of the newer medications that patients may have heard about in television, newspaper, and magazine advertising. In addition, patients often ask for advice regarding various herbal or nonprescription medications for weight loss. In this article, the authors help physicians prepare to address these questions.
引用
收藏
页码:75 / +
页数:6
相关论文
共 23 条
  • [1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension
    Abenhaim, L
    Moride, Y
    Brenot, F
    Rich, S
    Benichou, J
    Kurz, X
    Higenbottam, T
    Oakley, C
    Wouters, E
    Aubier, M
    Simonneau, G
    Begaud, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) : 609 - 616
  • [2] Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine
    Apfelbaum, M
    Vague, P
    Ziegler, O
    Hanotin, C
    Thomas, F
    Leutenegger, E
    [J]. AMERICAN JOURNAL OF MEDICINE, 1999, 106 (02) : 179 - 184
  • [3] What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice
    Astrup, A
    Lundsgaard, C
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 : 29 - 34
  • [4] Garcinia cambogia for weight loss
    Badmaev, V
    Majeed, M
    Conte, AA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03): : 233 - 234
  • [5] BECKWITH C, 1999, PHARM LETT MAR, P16
  • [6] Valvular heart disease associated with fenfluramine-phentermine
    Connolly, HM
    Crary, JL
    McGoon, MD
    Hensrud, DD
    Edwards, BS
    Edwards, WD
    Schaff, HV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) : 581 - 588
  • [7] Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat - A randomized controlled trial
    Davidson, MH
    Hauptman, J
    DiGirolamo, M
    Foreyt, JP
    Halsted, CH
    Heber, D
    Heimburger, DC
    Lucas, CP
    Robbins, DC
    Chung, J
    Heymsfield, SB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (03): : 235 - 242
  • [8] LONG-TERM WEIGHT-LOSS - THE EFFECT OF PHARMACOLOGICAL AGENTS
    GOLDSTEIN, DJ
    POTVIN, JH
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1994, 60 (05) : 647 - 657
  • [9] Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent -: A randomized controlled trial
    Heymsfield, SB
    Allison, DB
    Vasselli, JR
    Pietrobelli, A
    Greenfield, D
    Nunez, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18): : 1596 - 1600
  • [10] Hill JO, 1999, AM J CLIN NUTR, V69, P1108